Jane Street’s Marker Therapeutics MRKR Stock Holding History

Jane Street’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.7K	Sell	16,832 -19,471	-54%	-$28.4K	﹤0.01%	11151
2026 Q1	$47.2K	Sell	36,303 -4,215	-10%	-$6.69K	﹤0.01%	10992
2025 Q4	$60.4K	Buy	+40,518	New	+$45.9K	﹤0.01%	10435
2025 Q3	–	Sell	-21,800	Closed	-$33.4K	–	11408
2025 Q2	$33.4K	Buy	+21,800	New	+$28K	﹤0.01%	9272
2023 Q1	–	Sell	-1,237	Closed	-$3.29K	–	9588
2022 Q4	$3.29K	Buy	+1,237	New	+$4.27K	﹤0.01%	8900
2022 Q3	–	Sell	-6,538	Closed	-$22K	–	10162
2022 Q2	$22K	Buy	+6,538	New	+$21.7K	﹤0.01%	9137
2022 Q1	–	Sell	-8,518	Closed	-$81K	–	10763
2021 Q4	$81K	Buy	+8,518	New	+$113K	﹤0.01%	9331
2021 Q3	–	Sell	-2,519	Closed	-$51.6K	–	10430
2021 Q2	$70K	Buy	2,519 +42	+2%	+$1.11K	﹤0.01%	9406
2021 Q1	$55K	Buy	+2,477	New	+$56.7K	﹤0.01%	8814
2020 Q4	–	Sell	-2,441	Closed	-$37K	–	7872
2020 Q3	$37K	Buy	+2,441	New	+$44.5K	﹤0.01%	6963

Other funds holding MRKR

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street's MRKR Position: Q2 2026 in Review

Jane Street reduced its Marker Therapeutics (MRKR) stake by 54% in Q2 2026, selling an estimated $28.4K and leaving 16,832 shares worth $24.7K. The position accounts for ﹤0.01% of the portfolio, ranked #11151.

Jane Street first reported a position in MRKR in Q3 2020 and has held it in 10 quarters since. The position peaked at $81K in Q4 2021. 34 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

Jane Street held 16,832 shares of Marker Therapeutics worth $24.7K as of Q2 2026.
Jane Street sold 19,471 Marker Therapeutics shares in Q2 2026, an estimated $28.4K.
Marker Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11151 holding.
Jane Street first reported a position in Marker Therapeutics in Q3 2020 and has held it in 10 quarters since.
Jane Street's Marker Therapeutics position peaked at $81K in Q4 2021.
34 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.